| Effect of colonoscopy volume on quality indicators D Pace, M Borgaonkar, M Lougheed, C Marcoux, B Evans, N Hickey, ... Canadian Journal of Gastroenterology and Hepatology 2016 (1), 2580894, 2016 | 25 | 2016 |
| Prospective assessment of an automated intraprocedural 12-lead ECG-based system for localization of early left ventricular activation S Zhou, A AbdelWahab, BM Horáček, PJ MacInnis, JW Warren, JS Davis, ... Circulation: Arrhythmia and Electrophysiology 13 (7), e008262, 2020 | 24 | 2020 |
| Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS C Marcoux, D Marin, J Ramdial, G AlAtrash, AM Alousi, B Oran, ... American journal of hematology 98 (5), 712-719, 2023 | 16 | 2023 |
| Annual colonoscopy volume and maintenance of competency for surgeons D Pace, M Borgaonkar, B Evans, C Marcoux, M Lougheed, V Falk, ... Surgical Endoscopy 31, 2630-2635, 2017 | 14 | 2017 |
| Natural history of tumor thrombus: a single-centre retrospective study C Marcoux, S Al Ghamdi, D Manos, MM Keating, SP Shivakumar Blood 134, 2430, 2019 | 13 | 2019 |
| Balanced ionotropic receptor dynamics support signal estimation via voltage-dependent membrane noise CM Marcoux, SE Clarke, WH Nesse, A Longtin, L Maler Journal of Neurophysiology 115 (1), 530-545, 2016 | 13 | 2016 |
| Canadian association of gastroenterology indicators of safety compromise following colonoscopy in clinical practice MR Borgaonkar, D Pace, M Lougheed, C Marcoux, B Evans, N Hickey, ... Canadian Journal of Gastroenterology and Hepatology 2016 (1), 2729871, 2016 | 12 | 2016 |
| HLA factors versus non-HLA factors for haploidentical donor selection RS Mehta, K Cao, RM Saliba, G Al-Atrash, AM Alousi, K Lontos, ... Transplantation and cellular therapy 29 (3), 189-198, 2023 | 8 | 2023 |
| Does the hands-on, technical training of residents in colonoscopy affect quality outcomes? D Pace, M Borgaonkar, N Hickey, B Evans, M Lougheed, C Marcoux, ... Surgical endoscopy 30, 1352-1355, 2016 | 8 | 2016 |
| Trends in Outcomes over Three Decades after Upfront Autologous Stem Cell Transplant for Multiple Myeloma at MD Anderson Cancer Center O Pasvolsky, C Marcoux, J Dai, DR Milton, MR Tanner, N Syed, Q Bashir, ... Blood 142, 4962, 2023 | 4 | 2023 |
| Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study D Maze, MO Arcasoy, R Henrie, S Cerquozzi, R Kamble, S Al-Hadidi, ... Bone Marrow Transplantation 59 (2), 196-202, 2024 | 3 | 2024 |
| Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation C Marcoux, RM Saliba, W Wallis, S Khazal, D Ragoonanan, G Rondon, ... Blood Advances 8 (5), 1128-1136, 2024 | 2 | 2024 |
| Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17p C Marcoux, O Pasvolsky, DR Milton, MR Tanner, Q Bashir, S Srour, ... Transplantation and Cellular Therapy 31 (1), 12. e1-12. e10, 2025 | 1 | 2025 |
| Outcomes of young adults (aged≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant O Pasvolsky, C Marcoux, DR Milton, MR Tanner, Q Bashir, S Srour, ... British Journal of Haematology 202 (4), 866-873, 2023 | 1 | 2023 |
| Role of Allogeneic Hematopoietic Cell Transplant in Patients with Myelofibrosis in the JAK Inhibitor Era D Maze, MO Arcasoy, R Henrie, S Cerquozzi, R Kamble, S Al Hadidi, ... Blood 136, 52-53, 2020 | 1 | 2020 |
| Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation O Pasvolsky, C Marcoux, Z Wang, DR Milton, B Pal, MR Tanner, Q Bashir, ... Transplantation and Cellular Therapy, 2024 | | 2024 |
| Transplant in ALL: who, when, and how? C Marcoux, P Kebriaei Hematology 2024 (1), 93-101, 2024 | | 2024 |
| Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease CM Marcoux, AM Alousi, J Im, LC Hill, P Smallbone, U Popat, C Hosing, ... Bone marrow transplantation 59 (11), 1594-1600, 2024 | | 2024 |
| Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation O Pasvolsky, C Marcoux, DR Milton, B Pal, MR Tanner, Q Bashir, S Srour, ... Blood cancer journal 14 (1), 189, 2024 | | 2024 |
| Bone marrow necrosis and hyperinflammation after treatment with inotuzumab ozogamicin for B-cell acute lymphoblastic leukaemia C Marcoux, P Thakkar, DM Conrad, AA Shawwa, LYC Chen The Lancet 404 (10459), 1253-1254, 2024 | | 2024 |
